Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Visser

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Nuclear Medicine and Biology|January 1, 1980
Electrophilically astatinated proteinsG W Visser, F M Kaspersen
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1988
Synthesis of 18F-labelled 2-fluoro-1,4-quinones using acetylhypofluoriteJ D Herscheid, R Wedzinga, W Verboom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
In vitro antiproliferative and metabolic activity of eight novel 5-fluorinated uracil nucleosidesB J Braakhuis, G W Visser, I Stringer, et al.
European Journal of Nuclear Medicine|January 1, 1989
An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agentG W Visser, G C Gorree, B J Braakhuis, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Synthesis of 18F-labelled VP 16-213 and podophyllotoxin using acetyl hypofluoriteG W Visser, A T Bijma, J A Dijksman, et al.
The International Journal of Applied Radiation and Isotopes|December 1, 1981
The biological behaviour of some organic astatine compounds in ratsG W Visser, E L Diemer, C M Vos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and doseG W Visser, G C Gorree, G J Peters, et al.
Nuclear Medicine Communications|August 1, 1985
Synthesis and biodistribution of [18F]-5-fluorocytosineG W Visser, S Boele, G H Knops, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocolG W Visser, M Gerretsen, J D Herscheid, et al.
European Journal of Nuclear Medicine|January 1, 1986
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidineG W Visser, O Zwaagstra, G C Gorree, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Nuclear Medicine and Biology|January 1, 1980
Electrophilically astatinated proteinsG W Visser, F M Kaspersen
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1988
Synthesis of 18F-labelled 2-fluoro-1,4-quinones using acetylhypofluoriteJ D Herscheid, R Wedzinga, W Verboom, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
In vitro antiproliferative and metabolic activity of eight novel 5-fluorinated uracil nucleosidesB J Braakhuis, G W Visser, I Stringer, et al.
European Journal of Nuclear Medicine|January 1, 1989
An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agentG W Visser, G C Gorree, B J Braakhuis, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Synthesis of 18F-labelled VP 16-213 and podophyllotoxin using acetyl hypofluoriteG W Visser, A T Bijma, J A Dijksman, et al.
The International Journal of Applied Radiation and Isotopes|December 1, 1981
The biological behaviour of some organic astatine compounds in ratsG W Visser, E L Diemer, C M Vos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and doseG W Visser, G C Gorree, G J Peters, et al.
Nuclear Medicine Communications|August 1, 1985
Synthesis and biodistribution of [18F]-5-fluorocytosineG W Visser, S Boele, G H Knops, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocolG W Visser, M Gerretsen, J D Herscheid, et al.
European Journal of Nuclear Medicine|January 1, 1986
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidineG W Visser, O Zwaagstra, G C Gorree, et al.
Pageof 3